Delivery Order SPE2DB24D2205-SPE2DB25FEHUN
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,620.28 by the Defense Logistics Agency's Medical Supply Chain for the delivery of MENVEO VACCINE VL 5S, a meningococcal vaccine product. The contract, awarded on September 12, 2025, utilizes firm fixed pricing with an ultimate completion date of October 9, 2025. This is a competitive award with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $25,338.10 firm fixed-price delivery order from the Defense Logistics Agency on September 15, 2025, for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccines. This is a non-set-aside competitive award with an ultimate completion date of September 16, 2025, and performance will occur at the company's Conshohocken, PA facility. The delivery order is issued as a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at approximately $45K on July 23, 2025, for the supply of Menveo vaccine (5-dose vials). This competitively awarded, firm fixed-price delivery order is expected to be completed by July 24, 2025, and will be performed at the contractor's Conshohocken facility. The award was funded by the Defense Logistics Agency's Medical Supply Chain, which procures...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $13,616.96 firm fixed-price delivery order by the Defense Logistics Agency on September 17, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials). The contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,375.92 for the Menveo vaccine (5-dose vial) by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of September 17, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at $14,049.60 by the Defense Logistics Agency (DLA) to supply one vial of MENVEO, a meningococcal vaccine. Performance will occur at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by November 16, 2023. As a prime contractor, Amerisourcebergen provides pharmaceutical products and medical supplies to DLA Troop Support Medical to support military treatment programs. No set-aside...
- AmerisourceBergen Drug Corp was awarded a $38,694 delivery order by the Defense Logistics Agency (DLA) on June 12, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This competitively awarded, firm fixed price contract carries no set-aside designation and has an ultimate completion date of June 13, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $3,512.40 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply one vial of MENVEO, a meningococcal vaccine. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania with completion by December 1, 2023. The delivery order was issued against an indefinite-delivery contract with no set-aside designation used. As a leading...
- Amerisourcebergen Drug Corporation, doing business as Amerisourcebergen, has been awarded a $3,025.90 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply one vial of MENVEO, a meningococcal vaccine. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all work to be completed by December 13, 2023. The delivery order was issued against an indefinite-delivery contract held by Amerisourcebergen with no...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.66 to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The award was made on May 16, 2025, with an ultimate completion date of May 19, 2025, utilizing firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHUNDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a $24,637.20 delivery order by the Defense Logistics Agency (DLA) for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 22, 2025, and will be performed at the company's Conshohocken location. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger prime Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. The company maintains a broad portfolio of pharmaceutical products and medical supplies spanning multiple therapeutic domains, and this vaccine delivery order falls within its established capability to supply essential medical commodities to support military healthcare programs globally. No set-aside designation was applied to this award, reflecting AmerisourceBergen Drug Corp's competitive positioning among federal contractors in the pharmaceutical distribution sector.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.6k | 9/19/25 |